会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
    • 黄嘌呤酸衍生物药物组合物及其相关方法
    • US20060142248A1
    • 2006-06-29
    • US11027131
    • 2004-12-29
    • Neal BrickerStewart ShankelChristopher CainMark MitchnickMichael Schmertzler
    • Neal BrickerStewart ShankelChristopher CainMark MitchnickMichael Schmertzler
    • A61K31/4709A61K31/4706A61K31/675
    • C07D215/48A61K31/341A61K31/47A61K31/4706A61K31/4709A61K31/635A61K31/675A61K31/706A61K45/06C07H17/02G01N33/5308G06K19/02G06K19/07749G06K19/0776A61K2300/00
    • The present invention relates to diuretic pharmaceutical compositions and methods and in particular to certain derivatives of the formula I wherein R1, R2, R3, R5, R6 and R7 are independently X3R where R is selected from the group consisting of H, halo; optionally substituted saccharide, aliphatic, cycloalkyl, heterocycloalkyl, aryl and heteroaryl; —P(O)(ORa)(ORb) and —NRaRb, where Ra and Rb are independently H, optionally substituted aliphatic, cycloalkyl, heterocycloalkyl, aryl or heteroaryl; X1, X2 and X3 are independently —C(O)O—, —OC(O)—, —C(O)NH—, —NHC(O)—, —OC(O)NH—, —NHC(O)O—, —OS(O)y—, —S(O)y—, —O—, —NHC(O)—, —NHC(O)O—, —S(O)2NH—, a bond or absent; where y is an integer from 0 to 3; and R4 and R8 are independently H, (═O); hydroxy; or optionally substituted saccharide, aliphatic, cycloalkyl, heterocycloalkyl, aryl or heteroaryl; or —P(O)(ORa)(ORb) or —NRaRb, where Ra and Rb are independently H, or optionally substituted aliphatic, cycloalkyl or heterocycloalkyl, aryl or heteroaryl; or a prodrug or pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier.
    • 本发明涉及利尿药物组合物和方法,特别涉及式I的某些衍生物,其中R 1,R 2,R 3, R 5,R 6和R 7独立地是X 3 R,其中R选自 的H,卤素; 脂肪族,环烷基,杂环烷基,芳基和杂芳基; -P(O)(OR a)a(OR b)和-NR a R b B,其中R H和R b独立地为H,任选取代的脂族,环烷基,杂环烷基,芳基或杂芳基; X 1,X 2和X 3独立地是-C(O)O-,-OC(O) - , - C(O )NH-,-NHC(O) - , - OC(O)NH - , - NHC(O)O-,-OS(O)y - , - S(O) (O) - , - O(O)2 - , - (O)2 NH-,键或不存在; 其中y是0至3的整数; 和R 4和R 8独立地是H,( - O); 羟基; 或任选取代的糖,脂族,环烷基,杂环烷基,芳基或杂芳基; 或-P(O)(OR a)或(OR b))或-NR a R b B,其中 R a和R b独立地是H或任选取代的脂族,环烷基或杂环烷基,芳基或杂芳基; 或其前药或药学上可接受的盐; 和药学上可接受的载体。